| - IKF/AIO-QUINTIS - Evaluating Fruquintinib in Combination With Tislelizumab in Microsatellite S | Phase II | rekrutiert |
| A Clincial Study Testing Tirzepatide on Reproductive Function and Metabolic Health in Women With | Phase IV | rekrutiert |
| A Clinical Study to Improve Brain Function and Quality of Life of Patients With Newly Diagnosed | Phase III | rekrutiert |
| A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With B | Phase III | rekrutiert |
| A Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial f | Phase I / Phase II | rekrutiert |
| A Double Blind Study Performed to Evaluate the Efficacy and the Safety of EscharEx in Debridemen | Phase III | rekrutiert |
| A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Trea | Phase III | rekrutiert |
| A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Trea | Phase III | rekrutiert |
| A Global Prospective Observational Registry of Patients With Pompe Disease | — | rekrutiert |
| A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesit | Phase III | rekrutiert |
| A NIS Evaluating Various Injectable and Oral Treatments in Patients With Relapsing Multiple Scle | — | rekrutiert |
| A Natural History Study in Participants With Congenital Myasthenic Syndromes (CMS) Due to Mutati | — | rekrutiert |
| A Non-Interventional Study in Participants With Indolent Systemic Mastocytosis (ISM) in Germany | — | rekrutiert |
| A Non-interventional Study for Kisqali (Ribociclib) in Combination With an Aromatase Inhibitor f | — | rekrutiert |
| A Non-interventional, Post-authorisation Safety Study of Patients Treated With Efgartigimod Alfa | — | rekrutiert |
| A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Sa | Phase III | rekrutiert |
| A Phase III Study to Investigate Efficacy, Safety and Tolerability of Iptacopan Compared With Pl | Phase III | rekrutiert |
| A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo i | Phase III | rekrutiert |
| A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in | Phase II | rekrutiert |
| A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart | Phase III | rekrutiert |
| A Research Study to See How a Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar | Phase III | rekrutiert |
| A Safety and Pharmacokinetics Trial of VO659 in SCA1, SCA3 and HD | Phase I / Phase II | rekrutiert |
| A Study Evaluating BFB759 in Moderate to Severe Hidradenitis Suppurativa | Phase II / Phase III | rekrutiert |
| A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients W | Phase I | rekrutiert |
| A Study With CIT-013 in HS Patients | Phase II | rekrutiert |
| A Study of Clinical Outcomes in Participants With EGFR Mutated Advanced Non-Small Cell Lung Canc | — | rekrutiert |
| A Study of HyQvia in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP | — | rekrutiert |
| A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) | Phase II | rekrutiert |
| A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembroliz | Phase III | rekrutiert |
| A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Osteoarthriti | Phase III | rekrutiert |
| A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease | Phase III | rekrutiert |
| A Study of Zasocitinib in Adults With Hidradenitis Suppurativa | Phase II | rekrutiert |
| A Study of the Efficacy and Safety of Adjuvant Autogene Cevumeran Plus Atezolizumab and mFOLFIRI | Phase II | rekrutiert |
| A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult an | Phase III | rekrutiert |
| A Study to Assess NAV-240 in Adult Participants With Hidradenitis Suppurativa | Phase II | rekrutiert |
| A Study to Evaluate ALN-HTT02 in Adult Patients With Huntington's Disease | Phase I | rekrutiert |
| A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-M | Phase III | rekrutiert |
| A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Palmoplant | Phase III | rekrutiert |
| A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants Wit | Phase III | rekrutiert |
| A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Mul | Phase II | rekrutiert |
| A Study to Evaluate the Safety and Efficacy of BGB-16673 Compared to Pirtobrutinib in Adults Wit | Phase III | rekrutiert |
| A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus | Phase II / Phase III | rekrutiert |
| A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of RO7268489 as | Phase II | rekrutiert |
| A Study to Investigate Effects of Ocrelizumab Treatment on Neurofilament Light Chain (NfL) Level | — | rekrutiert |
| A Study to Investigate OCS Tapering in Adult Participants With Generalized Myasthenia Gravis Tre | Phase IV | rekrutiert |
| A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Part | Phase II | rekrutiert |
| A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenou | Phase III | rekrutiert |
| A Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in P | Phase I / Phase II | rekrutiert |
| A Worldwide Pregnancy Safety Study to Assess Maternal, Fetal, and Infant Outcomes Following Expo | — | rekrutiert |
| AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Exc | Phase III | rekrutiert |
| AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Exc | Phase III | rekrutiert |
| Adjusted High-dose Chemotherapy With Autologous Stem Cell Transplant vs. Conventional Immunochem | Phase III | rekrutiert |
| An Open-label Study to Assess the Safety, Efficacy, and Cellular Kinetics of YTB323 in Relapsing | Phase I / Phase II | rekrutiert |
| An Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in | Phase III | rekrutiert |
| BRAF Inhibitor Encorafenib And Cetuximab Real Life Investigation of Next Generation CRC Treatmen | — | rekrutiert |
| Bleximenib in Combination With Standard Induction and Consolidation Therapy Followed by Maintena | Phase III | rekrutiert |
| BoStOn SCientific Rhythm MAnagemenT REgiStry (SOCRATES) | — | rekrutiert |
| Brivekimig for the Treatment of Moderate to Severe Hidradenitis Suppurativa | Phase II | rekrutiert |
| Clinical AML Registry and Biomaterial Database of the Study Alliance Leukemia (SAL) | — | rekrutiert |
| Clinical Impact Through AI-assisted MS Care - A Retrospective Multi-center Observational Study. | — | rekrutiert |
| Comparative Effectiveness and Safety of ELIOS in Patients With Open-Angle Glaucoma Undergoing Ca | ohne Phasenangabe | rekrutiert |
| Complete Revascularization Versus Culprit Lesion Only PCI in NSTEMI | ohne Phasenangabe | rekrutiert |
| CytOSorb TreatMent Of Critically Ill PatientS Registry | — | rekrutiert |
| Dexamethasone Eluting Cochlear Implant: a Pivotal Study | ohne Phasenangabe | rekrutiert |
| EAST-1 (ERAP-inhibition in Axial Spondyloarthritis Trial - 1) | Phase I / Phase II | rekrutiert |
| EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in Peop | Phase III | rekrutiert |
| Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Poly | Phase II / Phase III | rekrutiert |
| Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain an | Phase III | rekrutiert |
| Efficacy and Safety of MB-CART2019.1 vs. SoC in Lymphoma Patients | Phase II | rekrutiert |
| Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With | Phase III | rekrutiert |
| Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participant | Phase III | rekrutiert |
| Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort | — | rekrutiert |
| Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With | Phase III | rekrutiert |
| GENERATE - Next GENERATion of GynEcological Surgery - Robotic Assisted Surgery in Gynecological | — | rekrutiert |
| GMALL Registry and Collection of Biomaterial: Prospective Data Collection Regarding Diagnosis, T | — | rekrutiert |
| GMMG Multiple Myeloma Registry | — | rekrutiert |
| HDClarity: a Multi-site Cerebrospinal Fluid Collection Initiative to Facilitate Therapeutic Deve | — | rekrutiert |
| ITP Registry and Accompanying Biospecimen Collection | — | rekrutiert |
| Imeroprubart in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) | Phase II | rekrutiert |
| In Vivo Exposure vs. Videochat-Based Vicarious Exposure | ohne Phasenangabe | rekrutiert |
| Ivosidenib and Azacitidine With or Without Venetoclax in Adult Patients With Newly Diagnosed IDH | Phase III | rekrutiert |
| KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generali | Phase II / Phase III | rekrutiert |
| LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Cal | Phase III | rekrutiert |
| LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MAS | Phase III | rekrutiert |
| Lomustine With and Without Reirradiation for First Progression of Glioblastoma: a Randomized Pha | Phase III | rekrutiert |
| MED-EL HEARING SOLUTIONS (MEHS): AN OBSERVATIONAL STUDY | — | rekrutiert |
| Mental Health and Suicidality in Glioblastoma Patients in Germany | — | rekrutiert |
| Neurovascular Product Surveillance Registry | — | rekrutiert |
| Observational Study Protocol: LIVER-R | — | rekrutiert |
| Observational Study for Assessing Treatment and Outcome of Patients With Primary Brain Tumours U | — | rekrutiert |
| PROtective Ventilation With FLOW-Controlled Ventilation | ohne Phasenangabe | rekrutiert |
| Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combinat | Phase III | rekrutiert |
| Phase III Study of Induction and Consolidation Chemotherapy With Venetoclax in Patients With New | Phase III | rekrutiert |
| Pompe Disease Registry Protocol | — | rekrutiert |
| Post-resection/Ablation Chemotherapy in Patients With Metastatic Colorectal Cancer (FIRE-9 - POR | Phase III | rekrutiert |
| Pregnancy Exposure Registry for Vumerity (Diroximel Fumarate) | — | rekrutiert |
| Pridopidine Phase 3 Study in Huntington's Disease | Phase III | rekrutiert |
| Product Surveillance Registry | — | rekrutiert |
| Prospective, Randomized Trial of Personalized Medicine With Pentaglobin® After Surgical Infectio | Phase II | rekrutiert |
| Randomised Evaluation of Sodium Dialysate Levels on Vascular Events | Phase IV | rekrutiert |
| Randomized Controlled Trial of Remote Symptoms Monitoring With Resilience PRO Compared to Care A | Phase III | rekrutiert |
| Randomized Trial in Adult de Novo Ph Positive ALL With Chemotherapy, Imatinib or Ponatinib, Blin | Phase II | rekrutiert |
| Real-World Efgartigimod Effectiveness in CIDP: A Prospective Study | — | rekrutiert |
| Registry Study of Assistive Devices, Medicines and Healthcare Measures in ALS, SMA and Other Neu | — | rekrutiert |
| Registry Study on Patient Characteristics, Biological Disease Profile and Clinical Outcome in Ac | — | rekrutiert |
| Registry for Patients With X-Linked Hypophosphatemia | — | rekrutiert |
| Revumenib in Combination With Azacitidine + Venetoclax in Patients NPM1-mutated or KMT2A-rearran | Phase III | rekrutiert |
| Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib | Phase III | rekrutiert |
| SL-START - SubLingual Apomorphine Schemes of TitrAtion in Real-world Treatment | — | rekrutiert |
| Safety and Efficacy of Intravenous Thrombolysis in Patients With Ischemic Stroke and Direct Oral | Phase IV | rekrutiert |
| Study of Sacituzumab Govitecan Versus Standard of Care in Participants With Previously Treated E | Phase III | rekrutiert |
| Study to Assess Change in Disease Activity of Risankizumab Treatment in Adult Participants With | — | rekrutiert |
| Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe General | Phase III | rekrutiert |
| The ABC-HCC Trial: Atezolizumab Plus Bevacizumab vs. Transarterial Chemoembolization (TACE) in I | Phase III | rekrutiert |
| The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis | Phase III | rekrutiert |
| The EUROSCA Natural History Study | — | rekrutiert |
| The LYMPH Trial - Microsurgical Versus Conservative Treatment of Chronic Breast Cancer Associate | ohne Phasenangabe | rekrutiert |
| The ReTAVI Prospective Observational Registry | — | rekrutiert |
| Trial of Preoperative Radiosurgery Versus Postoperative Stereotactic Radiotherapy for Resectable | ohne Phasenangabe | rekrutiert |
| Trial to Evaluate Efficacy and Safety of Bortezomib in Patients With Severe Autoimmune Encephali | Phase II | rekrutiert |
| Ultra-high-caloric, Fatty Diet in ALS | ohne Phasenangabe | rekrutiert |